KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Rigel Pharmaceuticals (RIGL) Long-Term Debt Issuances: 2022-2023

Historic Long-Term Debt Issuances for Rigel Pharmaceuticals (RIGL) over the last 1 years, with Mar 2023 value amounting to $19.9 million.

  • Rigel Pharmaceuticals' Long-Term Debt Issuances rose 100.00% to $19.9 million in Q1 2023 from the same period last year, while for Mar 2023 it was $39.5 million, marking a year-over-year change of. This contributed to the annual value of $19.9 million for FY2023, which is 2.09% up from last year.
  • Latest data reveals that Rigel Pharmaceuticals reported Long-Term Debt Issuances of $19.9 million as of Q1 2023, which was up 107.81% from $9.6 million recorded in Q3 2022.
  • Over the past 5 years, Rigel Pharmaceuticals' Long-Term Debt Issuances peaked at $19.9 million during Q1 2023, and registered a low of -$33,000 during Q2 2022.
  • Moreover, its 2-year median value for Long-Term Debt Issuances was $9.8 million (2022), whereas its average is $9.9 million.
  • Data for Rigel Pharmaceuticals' Long-Term Debt Issuances shows a peak YoY surged of 100.00% (in 2023) over the last 5 years.
  • Rigel Pharmaceuticals' Long-Term Debt Issuances (Quarterly) stood at $9.6 million in 2022, then soared by 100.00% to $19.9 million in 2023.
  • Its Long-Term Debt Issuances was $19.9 million in Q1 2023, compared to $9.6 million in Q3 2022 and -$33,000 in Q2 2022.